2 August 2022To: ASX Limited20 Bridge StreetSydney NSW 2000Australia [email protected] for trading halt: The a2 Milk Company Limited (“a2MC”) (ASX Code: A2M)We request a trading halt to be applied to our securities (ASX: A2M) under ASX Listing Rule 17.1 and set out below details of the request as per the rules of ASX.We would like the trading halt to commence immediately.Our securities are also listed on NZX and have been placed into a trading halt by NZX.Reasons for trading halt: We have become aware of media speculation concerning the status of our application to the US Food and Drug Administration for permission to sell infant formula within the United States of America. We are requesting a trading halt to provide us with additional time to properly consider the current information and to consider new information as it becomes available, and inform the market.How long we want the trading halt to last: We request that the trading halt remain in place until the earlier ofa) an announcement to each of ASX and NZX regarding the information; and(b) the commencement of normal trading on ASX on Thursday, 4 August 2022.The event we expect to happen that will end the trading halt: The release of an announcement by us to each of ASX and NZX or the commencement of normal trading on ASX on Thursday, 4 August 2022 (whichever is earlier).Information to include in any market memorandum relating to the halt: The trading halt has been requested pending the release of an announcement by a2MC.We confirm that we are not aware of any reason why the trading halt should not be granted. Yours sincerelyJaron McVicarChief Legal and Sustainability Officer & Company Secretary The a2 Milk Company Limited
- Forums
- ASX - By Stock
- Ann: Pause In Trading
A2M
the a2 milk company limited
Add to My Watchlist
0.96%
!
$7.73

2 August 2022To: ASX Limited20 Bridge StreetSydney NSW...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.73 |
Change
-0.075(0.96%) |
Mkt cap ! $5.611B |
Open | High | Low | Value | Volume |
$7.87 | $7.87 | $7.71 | $4.558M | 587.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 13075 | $7.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.73 | 2237 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 5054 | 7.730 |
18 | 13088 | 7.720 |
18 | 17907 | 7.710 |
20 | 37520 | 7.700 |
9 | 8542 | 7.690 |
Price($) | Vol. | No. |
---|---|---|
7.740 | 6345 | 14 |
7.750 | 12873 | 15 |
7.760 | 12481 | 12 |
7.770 | 24355 | 11 |
7.780 | 26407 | 12 |
Last trade - 13.43pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online